Extra, extra!!! U.S.A descobrem que Adenosina em bolus pode ser útil no diagnóstico de coronariopatia 30 anos depois do Morcerf.

1a

.

http://www.sciencedirect.com/science/article/pii/S0894731715006161

.

Mais um artigo usando um método muito parecido com o descrito por Morcerf há mais de 30 anos e ainda sem o crédito devido.

.

Results

Rate-pressure product after regadenoson was higher in Optison than Definity patients (P = .004). Using a 50% diameter stenosis on quantitative angiography as a reference standard, overall sensitivity, specificity, and accuracy for combined WM and MP analysis were not different for both agents (Optison, 77%, 64%, and 73%; Definity, 80%, 74%, and 78%; P = NS). The sensitivity, specificity, and accuracy of WM analysis alone for Optison were 68%, 71%, and 69% compared with 60%, 72%, and 66% for Definity (P = NS). Adding MP analysis improved the sensitivity and accuracy of Definity for detecting both >50% and >70% stenoses (P < .001 vs WM), while MP analysis did not improve the sensitivity of Optison for detecting either >50 or >70% stenoses.

.

Os resultados não são capazes de animar os ecocardiografistas para um produto de uso complicado no país.

.

Deixe uma resposta